The Efficiency of Oxcarbazepine and Carbamazepine in the Management of Trigeminal Neuralgia: First Comparative Study in Bangladesh

Background: Trigeminal neuralgia (TNg) is considered as one of the most severe painful disorders in the orofacial region. Anticonvulsants are most commonly used for such pain management. Carbamazepine is considered as first line of drug for the pain management of TNg. But, a new medicine namely, oxcarbazepine, that is a keto derivative of Carbamazepine, recently caught attention for its promising effect as an anti-convulsant drugs. However, little is known about its effect and safety in TNg management in aspects of Bangladeshi patients. Here, in this study we aim to compare the effectiveness and tolerability of carbamazepine versus oxcarbazepine in the pain management of TNg. Methods: People Patient with TNg were identified while visiting Bangabandhu Sheikh Mujib Medical University for treatment purpose. Thirty patients with TNg were selected irrespective of age, gender, religion or socioeconomic status of the patients, and selection criteria. Patients were administrated with oxcarbazepine (group A) and carbamazepine (group B) for certain time, and data were collected during indicated follow up. Results: In this study, 53.3 % patients were found within 51-60 years age group, followed by (46.7%) were in the age group of 40-50. It was reported that 43.3% were male and 56.7% patients were female. In present study, pain was significantly reduced in group A compared to group B (p <0.001). The mean pain score in group B was 4.11+0.91, but promisingly in group A was 1.41+ 0.78. Although, after one month of treatment, we found adverse effects in 4 (26.7%) patients in group A and 9 (60.0%) patients in group B. However, after 6 months of treatment no side effect was observed in group A, but 11 (73.3%) patients had side effect in group B. Side effects were significantly decreased in group A after 3 and 6 months compared to group B (p<0.05). Conclusion: The significant analgesic effects of oxcarbazepine and its generally improved safety and tolerability profile compared to carbamazepine, suggest that oxcarbazepine will be an important addition to TNg pain management. Journal of Dentistry and Allied Science, Vol. 7 No 1: 35-44

Authors

Institutions

Publication Details

Journal
Journal of Dentistry and Allied Science
Published
2024-12-30
DOI
https://doi.org/10.3329/jdas.v7i1.78904
Citations
1
Primary Topic
Trigeminal Neuralgia and Treatments
Type
article
Field-Weighted Citation Impact
0.42
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Efficiency of Oxcarbazepine and Carbamazepine in the Management of Trigeminal Neuralgia: First Comparative Study in Bangladesh

Abu Saleh Muhammad Shahriar, Adnan Iqbal Qureshi, Md Nurul Afsar, Sabah Afroze et al.
1 citations
Journal of Dentistry and Allied Science
Trigeminal Neuralgia and Treatments
0.42
article

The Efficiency of Oxcarbazepine and Carbamazepine in the Management of Trigeminal Neuralgia: First Comparative Study in Bangladesh

Abu Saleh Muhammad Shahriar, Adnan Iqbal Qureshi, Md Nurul Afsar, Sabah Afroze, Md. Abdul Kader, M. Mahbub Alam, SMA Hossain, Saki Alam Urmi
article en
1 citations

Abstract

Background: Trigeminal neuralgia (TNg) is considered as one of the most severe painful disorders in the orofacial region. Anticonvulsants are most commonly used for such pain management. Carbamazepine is considered as first line of drug for the pain management of TNg. But, a new medicine namely, oxcarbazepine, that is a keto derivative of Carbamazepine, recently caught attention for its promising effect as an anti-convulsant drugs. However, little is known about its effect and safety in TNg management in aspects of Bangladeshi patients. Here, in this study we aim to compare the effectiveness and tolerability of carbamazepine versus oxcarbazepine in the pain management of TNg. Methods: People Patient with TNg were identified while visiting Bangabandhu Sheikh Mujib Medical University for treatment purpose. Thirty patients with TNg were selected irrespective of age, gender, religion or socioeconomic status of the patients, and selection criteria. Patients were administrated with oxcarbazepine (group A) and carbamazepine (group B) for certain time, and data were collected during indicated follow up. Results: In this study, 53.3 % patients were found within 51-60 years age group, followed by (46.7%) were in the age group of 40-50. It was reported that 43.3% were male and 56.7% patients were female. In present study, pain was significantly reduced in group A compared to group B (p <0.001). The mean pain score in group B was 4.11+0.91, but promisingly in group A was 1.41+ 0.78. Although, after one month of treatment, we found adverse effects in 4 (26.7%) patients in group A and 9 (60.0%) patients in group B. However, after 6 months of treatment no side effect was observed in group A, but 11 (73.3%) patients had side effect in group B. Side effects were significantly decreased in group A after 3 and 6 months compared to group B (p<0.05). Conclusion: The significant analgesic effects of oxcarbazepine and its generally improved safety and tolerability profile compared to carbamazepine, suggest that oxcarbazepine will be an important addition to TNg pain management. Journal of Dentistry and Allied Science, Vol. 7 No 1: 35-44

Journal of Dentistry and Allied ScienceVol. 7(1)
Govt. Dental College & Hospital (IN), Dhaka Medical College and Hospital (BD)
Good health and well-being
Openalex Percentile: Top 31%
Trigeminal Neuralgia and Treatments
0.42
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.